Development of primary varicella infection during infliximab treatment for psoriasis.
Balato
Nicola
N
Gaudiello
Francesca
F
Balato
Anna
A
Ayala
Fabio
F
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D002644:Chickenpox / Q000139:chemically induced*; D003879:Dermatologic Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D000069285:Infliximab